Snapshot · Johnson & Johnson (JNJ)

Data as of 2026-09-01T20:01:03.883Z

Fundamentals check

Market cap

$654.0B

P/E (TTM)

31.4

Gross margin

70.5%

Net margin

21.5%

ROE

25.7%

R&D / revenue

15.4%

Dividend yield

1.9%

FCF yield

2.9%

Latest dividend: $1.34/share (ex-date 2026-08-25, quarterly)

Summary

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

How it makes money

Revenue mix, latest fiscal year

• Innovative Medicine64.1%
• MedTech35.9%

Recent Events

• 2026-08-31T17:08:00.000Znegative

  Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

  可能与投资者电话会议公告相关，市场对三季度结果的预期导致股价下探

  Source: businesswire.com

• 2026-08-31T04:44:00.000Znegative

  Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.

  可能与投资组合更新相关，股价近期波动可能部分由市场轮动驱动

  Source: fool.com

• 2026-08-30T04:14:04.000Znegative

  Deutsche Bank AG Has $3.98 Billion Stake in Johnson & Johnson $JNJ

  可能与增持披露相关，市场对持仓变动产生短线压力

  Source: defenseworld.net

• 2026-08-28T12:46:10.000Zpositive

  Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?

  可能与现金分红前景相关，股价短期上涨并非唯一因素

  Source: zacks.com

• 2026-08-27T01:30:00.000Znegative

  Johnson & Johnson Just Got a Big FDA Win

  可能与FDA批准相关的积极消息恰逢市场调整，股价下行并非因果直接

  Source: fool.com

• 2026-08-18T00:00:00.000Zpositive

  Price move: JNJ rose 3.3%

  JNJ 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-07-30T00:00:00.000Znegative

  Price move: JNJ fell 3.7%

  JNJ 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-07-02T00:00:00.000Zpositive

  Price move: JNJ rose 3.6%

  JNJ 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-06-26T00:00:00.000Zpositive

  Price move: JNJ rose 4.0%

  JNJ 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

Analyst view

Avg price target $280.53 from 17 analysts (last quarter)

Insider & Congress activity

Open-market trades only; grants and exercises excluded

• 2026-08-17SellTaubert Jennifer L(officer: EVP, WWC. Innovative Medicine)15,000 shares
• 2026-08-13SellDuato Joaquin(director, officer: CEO and Chairman of the Board)102,315 shares
• 2026-08-13SellDuato Joaquin(director, officer: CEO and Chairman of the Board)20,976 shares
• 2026-08-06SellForminard Elizabeth(officer: EVP, Chief Legal Officer)6,574 shares
• 2026-08-06SellForminard Elizabeth(officer: EVP, Chief Legal Officer)9,344 shares

US Congress trading disclosures

• 2026-03-19John Boozman (AR)Sale$1,001 - $15,000

订阅每日简报

每个交易日开盘/收盘后，中文市场简报直达邮箱。免费，随时退订。

本内容仅为信息整理，不构成任何投资建议。